Ardelyx, Inc.
ARDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001437402
In the last 90 days, Ardelyx, Inc. insiders filed 0 open-market purchases and 9 sales; 250 institutions reported holding it in 13F filings for Q2 2026, worth $906.4M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Ardelyx, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 213
- +12 vs. Q3 2024
- Shares held
- 150.9M
- +8.43M (+5.9%) vs. Q3 2024
- Total value
- $765.2M
- −$216.2M (−22.0%) vs. Q3 2024
- New holders
- 46
- 76 more added
- Sold out
- 34
- 61 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 250 | $906.4M |
| Q1 2026 | 242 | $1.01B |
| Q4 2025 | 229 | $972.9M |
| Q3 2025 | 223 | $891.4M |
| Q2 2025 | 206 | $657.3M |
| Q1 2025 | 221 | $808.7M |
| Q4 2024 | 213 | $765.2M |
| Q3 2024 | 203 | $982.8M |
| Q2 2024 | 197 | $1.07B |
| Q1 2024 | 189 | $1.03B |
| Q4 2023 | 161 | $849.0M |
| Q3 2023 | 150 | $513.5M |
| Q2 2023 | 146 | $426.0M |
| Q1 2023 | 130 | $550.1M |
| Q4 2022 | 104 | $225.7M |
| Q3 2022 | 83 | $79.6M |
| Q2 2022 | 78 | $22.7M |
| Q1 2022 | 89 | $42.4M |
| Q4 2021 | 100 | $46.0M |
| Q3 2021 | 108 | $66.7M |
| Q2 2021 | 127 | $643.2M |
| Q1 2021 | 125 | $559.7M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Ardelyx, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 2,150,974 | $10.9M | 0.00% | +50,441+2.4% | Added |
| Goldman Sachs Group Inc | 2,157,252 | $10.9M | 0.00% | −212,600−9.0% | Reduced |
| Nuveen Asset Management, LLC | 2,170,999 | $11.0M | 0.00% | +4,038+0.2% | Added |
| Morgan Stanley | 2,421,698 | $12.3M | 0.00% | −712,788−22.7% | Reduced |
| Citadel Advisors LLC | 2,490,618 | $12.6M | 0.01% | +281,685+12.8% | Added |
| Millennium Management LLC | 2,963,480 | $15.0M | 0.01% | −1,048,400−26.1% | Reduced |
| Geode Capital Management, LLC | 5,509,730 | $27.9M | 0.00% | +21,988+0.4% | Added |
| Eventide Asset Management, LLC | 5,600,764 | $28.4M | 0.52% | −1,812,285−24.4% | Reduced |
| Macquarie Group Ltd | 10,346,592 | $52.5M | 0.06% | +1,398,144+15.6% | Added |
| State Street Corp | 11,592,914 | $58.8M | 0.00% | −548,936−4.5% | Reduced |
| Vanguard Group Inc | 14,362,659 | $72.8M | 0.00% | +767,111+5.6% | Added |
| BlackRock, Inc. | 18,521,477 | $93.9M | 0.00% | +694,542+3.9% | Added |
| Janus Henderson Group PLC | 24,387,941 | $123.6M | 0.06% | +2,858,061+13.3% | Added |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −921,711−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −300,432−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −298,761−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −135,000−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −111,374−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −103,128−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −105,336−100.0% | Sold out |
| Personal Cfo Solutions, LLC | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −74,137−100.0% | Sold out |
| North Star Asset Management Inc | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Keebeck Wealth Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −45,605−100.0% | Sold out |
| Ausdal Financial Partners, Inc. | 0 | $0 | 0.00% | −34,459−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −32,877−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −30,354−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −28,365−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −24,905−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −23,510−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −15,666−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −15,388−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −14,312−100.0% | Sold out |
| Cora Capital Advisors LLC | 0 | $0 | 0.00% | −12,462−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −11,978−100.0% | Sold out |
| Helen Stephens Group, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −3,556−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −1,328−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −1,064−100.0% | Sold out |
| Signature Resources Capital Management, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Planned Solutions, Inc. | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −116−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |
| Raymond James & Associates | – | – | – | – | Not filed |